BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22984202)

  • 1. Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function.
    Fang H; Placencio VR; DeClerck YA
    J Natl Cancer Inst; 2012 Oct; 104(19):1470-84. PubMed ID: 22984202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis.
    Bajou K; Peng H; Laug WE; Maillard C; Noel A; Foidart JM; Martial JA; DeClerck YA
    Cancer Cell; 2008 Oct; 14(4):324-34. PubMed ID: 18835034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
    Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
    Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.
    Gomes-Giacoia E; Miyake M; Goodison S; Rosser CJ
    Mol Cancer Ther; 2013 Dec; 12(12):2697-708. PubMed ID: 24072883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1.
    Zhu ED; Li N; Li BS; Li W; Zhang WJ; Mao XH; Guo G; Zou QM; Xiao B
    PLoS One; 2014; 9(8):e106049. PubMed ID: 25170877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
    Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
    J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling.
    Pedroja BS; Kang LE; Imas AO; Carmeliet P; Bernstein AM
    J Biol Chem; 2009 Jul; 284(31):20708-17. PubMed ID: 19487690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.
    Jing Y; Kovacs K; Kurisetty V; Jiang Z; Tsinoremas N; Merchan JR
    Mol Cancer Res; 2012 Oct; 10(10):1271-81. PubMed ID: 22912336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.
    Vyas AR; Singh SV
    Eur J Nutr; 2014 Apr; 53(3):843-52. PubMed ID: 24092501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.
    Masuda T; Hattori N; Senoo T; Akita S; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Kohno N
    Mol Cancer Ther; 2013 Nov; 12(11):2378-88. PubMed ID: 23990114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 in cancer research.
    Li S; Wei X; He J; Tian X; Yuan S; Sun L
    Biomed Pharmacother; 2018 Sep; 105():83-94. PubMed ID: 29852393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
    Sorrell AM; Shand JH; Tonner E; Gamberoni M; Accorsi PA; Beattie J; Allan GJ; Flint DJ
    J Biol Chem; 2006 Apr; 281(16):10883-9. PubMed ID: 16505491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.
    Thummarati P; Wijitburaphat S; Prasopthum A; Menakongka A; Sripa B; Tohtong R; Suthiphongchai T
    World J Gastroenterol; 2012 Jan; 18(3):244-50. PubMed ID: 22294827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells.
    Kenny S; Duval C; Sammut SJ; Steele I; Pritchard DM; Atherton JC; Argent RH; Dimaline R; Dockray GJ; Varro A
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G431-41. PubMed ID: 18599586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.